1477
COM:OCUMENSION
Ocumension Therapeutics
- Stock
Last Close
5.19
25/11 08:08
Market Cap
4.65B
Beta: -
Volume Today
1.48M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -209.41M - | -1.33B 532.97% | -2.26B 70.87% | -259.99M 88.52% | -402.23M 54.71% | -379.79M 5.58% | |
depreciation and amortization | 64K - | 1.21M 1,787.50% | 4.65M 285.10% | 13.90M 198.75% | 40.46M 191.11% | ||
deferred income tax | 159.98M - | 1.17B 632.82% | 1.79B 52.73% | 23.57M 98.68% | |||
stock based compensation | 3.68M - | 46.80M 1,171.48% | 293.59M 527.28% | 188.12M 35.93% | 218.79M 16.31% | 139.73M 36.14% | |
change in working capital | 2.35M - | 860K 63.45% | -22.31M 2,694.30% | -35.50M 59.11% | -12.88M 63.73% | ||
accounts receivables | -8.61M - | -28.14M 226.96% | -31.15M 10.71% | -33.28M 6.84% | |||
inventory | -259K - | -2.77M 968.73% | -1.97M 28.97% | -19.11M 872.08% | |||
accounts payables | 8.61M - | 28.14M 226.96% | 31.15M 10.71% | 33.28M 6.84% | |||
other working capital | 1.12M - | -19.54M 1,846.47% | -33.53M 71.58% | 6.24M 118.59% | |||
other non cash items | -20K - | -3.81M 18,970% | -14.19M 272.10% | -126.94M 794.44% | -44.80M 64.71% | 240.06M 635.82% | |
net cash provided by operating activities | -43.35M - | -108.09M 149.34% | -212.57M 96.67% | -196.85M 7.40% | -200.66M 1.93% | ||
investments in property plant and equipment | -278K - | -766K 175.54% | -304.61M 39,666.19% | -664.81M 118.25% | -310.00M 53.37% | ||
acquisitions net | 25K - | -119.37M - | -848K 99.29% | ||||
purchases of investments | -102.87M - | -2.04B 1,883.31% | -1.33B 34.97% | -3.14B 136.85% | -2.03B 35.27% | ||
sales maturities of investments | 36.71M - | 1.06B 2,792.11% | 2.40B 125.77% | 2.45B 2.04% | 2.56B 4.55% | ||
other investing activites | -240K - | -449K 87.08% | -16.28M 3,525.39% | 17.31M 206.32% | 16.29M 5.85% | ||
net cash used for investing activites | -66.66M - | -979.92M 1,370.02% | 629.70M 164.26% | -1.35B 313.64% | 229.15M 117.03% | ||
debt repayment | -939K - | -1.38M 47.18% | -3.81M 176.05% | -9.15M 139.76% | |||
common stock issued | 68.31M - | 21K 99.97% | 1.61B 7,671,990.48% | 684.73M 57.50% | 12.72M 98.14% | ||
common stock repurchased | -1.39M - | -11.00M 692.65% | |||||
dividends paid | -3.81M - | -9.15M 139.76% | |||||
other financing activites | 68.67M - | 1.24B 1,709.39% | -82.40M 106.63% | -6.86M 91.67% | 7.35M 207.19% | ||
net cash used provided by financing activities | 136.98M - | 1.24B 806.42% | 1.53B 23.01% | 668.85M 56.21% | -9.22M 101.38% | ||
effect of forex changes on cash | -1.34M - | 13.15M 1,080.25% | -102.57M 879.68% | -35.81M 65.09% | 25.56M 171.38% | ||
net change in cash | 25.63M - | 166.78M 550.73% | 1.84B 1,004.43% | -909.10M 149.36% | 44.83M 104.93% | ||
cash at beginning of period | 25.63M - | 192.40M 650.73% | 2.03B 957.32% | 1.13B 44.69% | 1.17B 3.98% | ||
cash at end of period | 25.63M - | 192.40M 650.73% | 2.03B 957.32% | 1.13B 44.69% | 1.17B 3.98% | 1.17B 0% | |
operating cash flow | -43.35M - | -108.09M 149.34% | -212.57M 96.67% | -196.85M 7.40% | -200.66M 1.93% | ||
capital expenditure | -278K - | -766K 175.54% | -304.61M 39,666.19% | -664.81M 118.25% | -310.00M 53.37% | ||
free cash flow | -43.63M - | -108.85M 149.50% | -517.18M 375.12% | -861.66M 66.61% | -510.66M 40.74% |
All numbers in HKD (except ratios and percentages)